GHK-Cu Dosage Guide

Evidence-based protocols for copper peptide GHK-Cu — injectable and topical dosing, reconstitution, injection technique, stacking with BPC-157, cycling, and safety.

Last reviewed February 24, 2026
SwissChems

Lab-Grade Research Peptide

GHK-Cu

50mg Vial

10% OFF WITH CODE PEPTIDEWIKI

Shop GHK-Cu

Affiliate link. No extra cost to you.

What Is GHK-Cu?

GHK-Cu (copper peptide GHK-Cu, or glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide with high affinity for copper(II) ions. It was first isolated from human plasma by Dr. Loren Pickart in 1973 and has been studied extensively since — with over 60 published studies spanning four decades across wound healing, collagen synthesis, anti-aging, and tissue remodeling.

What makes GHK-Cu unusual is the dual-route approach. Unlike most peptides in the research community, GHK-Cu has established protocols for both injectable and topical use, each targeting different goals. Injectable dosing provides systemic healing and tissue remodeling, while topical formulations target localized skin rejuvenation and wound repair. This guide covers both routes: injectable dosing for systemic healing, topical formulations for skin rejuvenation, reconstitution, stacking, safety, and how to choose the right route for your goals.

Use our Peptide Dosage to calculate your exact injectable dose based on vial size and concentration.

Dosing information in this guide is derived from animal studies, plasma concentration research, and community protocols — not from human clinical trials.

Key Characteristics:

  • Naturally occurringfound in human plasma, saliva, and urine; declines with age (200 ng/mL in youth, dropping to 80 ng/mL by age 60)
  • Copper deliverybinds and delivers copper ions, which are essential cofactors for enzymes involved in tissue repair, including superoxide dismutase and lysyl oxidase
  • Collagen synthesisstimulates production of collagen types I and III, decorin, elastin, and glycosaminoglycans
  • Wound healingaccelerates wound closure, attracts immune cells, and promotes angiogenesis (new blood vessel formation)
  • Anti-inflammatoryreduces inflammatory cytokines including TNF-alpha and IL-6
  • Gene modulationstudies show GHK-Cu affects expression of over 4,000 genes, resetting many toward a healthier expression profile associated with younger tissue
  • Dual routeseffective both systemically (injectable) and locally (topical) — one of the few peptides with established protocols for both

For a complete overview of its mechanism and research, see our full GHK-Cu profile. New to peptides? Start with the Beginner's Guide to Peptides.

How GHK-Cu Dosage Is Determined

GHK-Cu dosing is informed by decades of published research, primarily in wound healing and dermatology. Unlike many research peptides that rely solely on animal dose translation, GHK-Cu benefits from direct human studies (topical) and well-characterized plasma concentration data that help frame injectable dosing.

Published Research

GHK-Cu has one of the longest research histories of any peptide in this space. Key sources include topical studies using 1–2% GHK-Cu creams and serums in human subjects, injectable studies in animal models and cell cultures demonstrating tissue repair and gene modulation, and plasma concentration studies establishing that natural GHK-Cu levels decline from approximately 200 ng/mL in youth to 80 ng/mL by age 60.

Community & Practitioner Experience

Injectable GHK-Cu dosing at 1–2 mg per day subcutaneously emerged from practitioners and the research peptide community. This range is informed by the goal of restoring youthful plasma GHK-Cu levels while remaining within practical dosing parameters. Topical protocols are more standardized, with 1–2% concentrations supported by published human skin studies.

Strength of evidence: Strong for topical (multiple human studies demonstrating skin improvements). Moderate for injectable (animal data, plasma level studies, community experience). GHK-Cu has more direct human evidence for topical use than most research peptides have for any route of administration.

Injectable GHK-Cu Dosage Ranges

Injectable GHK-Cu is administered subcutaneously once daily. Dosing is straightforward compared to many peptides — most protocols use a fixed daily dose rather than weight-based calculations.

LevelDose per InjectionFrequencyDaily Total
Conservative0.5 mgOnce daily0.5 mg/day
Standard1.0 mgOnce daily1.0 mg/day
Aggressive2.0 mgOnce daily2.0 mg/day
Dosage Selection: Most users start at 1.0 mg once daily. The conservative 0.5 mg dose is used to assess tolerance. The aggressive 2.0 mg dose is typically reserved for acute wound healing or post-surgical protocols under practitioner guidance. Higher doses have not been shown to produce proportionally better results.

Verified sources for GHK-Cu

These vendors are vetted by PeptideWiki for purity testing and COA transparency.

SwissChems10% off
View all vendor deals·Affiliate links. Commission at no extra cost.

Topical GHK-Cu Protocols

Topical GHK-Cu is the best-studied route of administration, with multiple human trials demonstrating improvements in skin thickness, collagen density, firmness, and reduction of fine lines and photodamage. Topical products are widely available as over-the-counter cosmetic formulations.

FormulationConcentrationFrequencyApplication Area
Serum1–2% GHK-Cu1–2x dailyFace, neck, target areas
Cream0.5–1% GHK-Cu1–2x dailyFace, body, wound sites
Custom (compounded)1–3% GHK-Cu1–2x dailyPer provider instructions

Topical Application Tips

  • Apply to clean skin — after cleansing, before heavier creams or moisturizers
  • Consistency is key — daily application for 4–8 weeks before assessing results
  • No cycling needed — topical GHK-Cu can be used continuously as part of a daily skincare routine
  • Avoid combining with strong acids — do not layer with L-ascorbic acid (vitamin C) or high-concentration AHAs/BHAs, which can destabilize the copper peptide
  • Patch test first — apply to a small area on the inner forearm and wait 24 hours to check for irritation
Combined approach: Some users combine injectable GHK-Cu for systemic benefits with topical application for targeted skin rejuvenation. This dual-route approach addresses both internal tissue remodeling and external cosmetic improvement simultaneously.

Calculate Your Injectable GHK-Cu Dose

Injectable GHK-Cu is supplied as a lyophilized (freeze-dried) powder, typically in 5 mg, 10 mg, or 50 mg vials. You reconstitute it with bacteriostatic water, then draw your dose using an insulin syringe. The concentration depends on how much water you add to the vial.

Worked Example:

  • Vial size: 5 mg (5,000 mcg) of GHK-Cu
  • Bacteriostatic water added: 2 mL
  • Concentration: 5,000 mcg ÷ 2 mL = 2,500 mcg per mL
  • Target dose: 1.0 mg (1,000 mcg)
  • Volume to draw: 1,000 ÷ 2,500 = 0.4 mL = 40 units on an insulin syringe

Quick Reference — Common Vial Sizes

Vial / Bac WaterConcentration1.0 mg DoseDoses per Vial
5 mg / 2 mL2.5 mg/mL40 units (0.4 mL)5 doses
10 mg / 2 mL5.0 mg/mL20 units (0.2 mL)10 doses
50 mg / 5 mL10 mg/mL10 units (0.1 mL)50 doses

Calculate Your GHK-Cu Dose Instantly

Enter your GHK-Cu vial size, water volume, and desired dose — get instant calculations with zero manual math.

How to Reconstitute Injectable GHK-Cu

GHK-Cu comes as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before injection. The process is the same as for other peptides, with one notable difference: expect a slight blue or blue-green tint from the copper ion — this is completely normal.

Supplies Needed:

  • GHK-Cu lyophilized vial (5 mg, 10 mg, or 50 mg)
  • Bacteriostatic water (BAC water) — contains 0.9% benzyl alcohol as preservative
  • Insulin syringes (29–31 gauge, 0.5 mL or 1 mL) for injection
  • Alcohol swabs (70% isopropyl alcohol)
  • Clean, flat workspace
  • Optional: larger syringe (1–3 mL) for drawing bacteriostatic water if using a separate drawing needle

Steps

1

Wash Hands & Prepare Workspace

Wash hands thoroughly with soap and water. Lay out supplies on a clean surface: GHK-Cu vial, bacteriostatic water, insulin syringe, and alcohol swabs.

2

Remove the Vial Caps

Flip off the plastic caps from both the GHK-Cu vial and the bacteriostatic water vial. Swab both rubber stoppers with alcohol pads and let them air-dry for 10–15 seconds.

3

Draw Bacteriostatic Water

Using a fresh insulin syringe, draw your desired volume of bacteriostatic water. For a 5 mg vial, 2 mL is standard (yields 2,500 mcg per mL).

4

Add Water to the Peptide Calculator Vial

Insert the needle into the GHK-Cu vial through the rubber stopper. Angle the needle so the water runs down the inside glass wall — never squirt directly onto the powder cake. Release the plunger slowly.

5

Dissolve Gently & Observe Color

Remove the syringe. Let the vial sit for 1–2 minutes, then gently swirl or roll between your palms until the powder is fully dissolved. Expect a slight blue or blue-green tint — this is normal for copper peptides. Never shake.

6

Label & Refrigerate

Write the reconstitution date and concentration on the vial. Store refrigerated at 2–8°C. Use within 3–4 weeks.

Copper color note: Reconstituted GHK-Cu will have a characteristic blue or blue-green tint. This is the natural color of copper(II) ions in solution and indicates the copper is properly bound to the peptide. A colorless solution may indicate a product without copper or a quality issue.

Storage

  • Unreconstituted (powder): Store refrigerated (2–8°C) for maximum shelf life; room temperature is acceptable for short periods but reduces potency over time
  • Reconstituted (in bacteriostatic water): Must be refrigerated at 2–8°C; use within 3–4 weeks
  • Do not freeze: Freezing reconstituted GHK-Cu can damage the peptide structure through ice crystal formation
  • Protect from light and heat — keep the vial in its box or wrapped in foil, away from direct sunlight and temperatures above 25°C

For a detailed visual walkthrough, see our Reconstitution Guide.

GHK-Cu Dosage by Goal

GHK-Cu's dual-route flexibility means the optimal protocol varies significantly depending on what you're targeting. The table below summarizes common goal-specific approaches, followed by detailed breakdowns.

Skin Rejuvenation & Anti-Aging

The most widely studied use case for GHK-Cu. Topical formulations have demonstrated improvements in skin thickness, collagen density, firmness, elasticity, and reduction of fine lines in human studies. Injectable GHK-Cu adds systemic support for collagen synthesis and tissue remodeling. Many users combine both routes for maximum effect.

  • Injectable: 1.0 mg/day SubQ for 4–8 weeks
  • Topical: 1–2% serum, 2x daily, ongoing
  • Combined approach: Injectable for systemic collagen support + topical for localized skin improvement

Wound Healing & Post-Surgical Recovery

GHK-Cu accelerates wound closure, promotes angiogenesis, attracts immune cells, and stimulates collagen deposition. Injectable dosing is used systemically to support overall healing, while topical application is added to the wound area once initial granulation tissue has formed.

  • Injectable: 1–2 mg/day SubQ for 2–4 weeks
  • Topical: Apply to wound area once granulation begins
  • Note: Often stacked with BPC-157 for complementary healing mechanisms

Hair Growth Support

GHK-Cu has shown potential for supporting hair growth by stimulating hair follicle stem cells, increasing follicle size, and extending the anagen (growth) phase. Both topical scalp application and injectable protocols are used, often together.

  • Topical: 1–2% solution applied to scalp daily
  • Injectable: 1.0 mg/day SubQ for 8–12 weeks
  • Note: Hair growth is slow; allow 8–12 weeks for visible results

Systemic Anti-Inflammatory & Tissue Repair

GHK-Cu reduces inflammatory cytokines (TNF-alpha, IL-6) and modulates gene expression toward healthier patterns. Injectable dosing is used for general anti-inflammatory and tissue repair support, often as part of a broader recovery protocol.

  • Injectable: 1–2 mg/day SubQ for 4–8 weeks
  • Commonly stacked with: BPC-157 for comprehensive healing
Choosing your route: For cosmetic skin goals, start with topical — it has the strongest human evidence. For systemic healing, post-surgical recovery, or anti-inflammatory goals, injectable is preferred. For maximum effect on skin aging, combine both. Topical is lower commitment, lower cost, and does not require injection.

GHK-Cu Injection Guide

Subcutaneous (SubQ) Injection — Step by Step

1

Wash Hands & Prepare

Wash hands thoroughly with soap and water. Prepare a clean workspace with your syringe, alcohol swab, and reconstituted GHK-Cu vial.

2

Swab the Vial Stopper

Wipe the rubber stopper of the GHK-Cu vial with an alcohol swab. Let it air-dry for 10–15 seconds.

3

Draw Your Dose

Pull back the plunger to draw air equal to your dose volume. Insert the needle into the vial, push in the air, invert the vial, and slowly draw out your calculated dose. Tap out any air bubbles. The solution may have a slight blue/green tint — this is normal.

4

Select Injection Site

The abdomen (2–3 inches from the navel) or front of the thigh are the most common SubQ injection sites for GHK-Cu. Rotate sites daily to avoid irritation.

5

Clean the Injection Site

Swab the chosen injection site with a fresh alcohol pad. Allow to air-dry completely before injecting.

6

Inject

Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 45-degree angle into the pinched skin fold. Push the plunger slowly and steadily. Withdraw the needle and apply gentle pressure with the alcohol swab if needed.

7

Dispose Safely

Place the used syringe immediately into a sharps container. Never recap or reuse needles.

Site rotation: Rotate injection sites daily to minimize localized irritation. Alternate between left and right abdomen, left and right thigh. Consistent site rotation also ensures more even subcutaneous absorption.

GHK-Cu Cycle Duration & Timing

Injectable GHK-Cu is typically used in defined cycles, while topical GHK-Cu can be used continuously. The cycling recommendations below reflect community best practices and the general principle of periodic breaks for injectable peptides.

ProtocolDurationBest For
Standard injectable cycle4–8 weeks on, 4 weeks offSkin rejuvenation, general healing, anti-inflammatory
Extended injectable cycle8–12 weeks on, 4 weeks offHair growth support, chronic wound healing
Topical (ongoing)Continuous — no cycling neededDaily skincare, cosmetic maintenance

Time of Day

  • Injectable: Once daily at any consistent time. Morning is most common, but GHK-Cu does not need to be timed around meals, workouts, or sleep.
  • Topical (serum): Apply in the morning after cleansing and/or in the evening as part of your skincare routine. Twice daily application provides better results than once daily.
  • Topical (wound healing): Apply once or twice daily after gently cleaning the wound area.
Why cycle injectable but not topical? Injectable peptides deliver systemic doses that affect the entire body, and periodic breaks allow assessment of progress and normalization. Topical application provides localized, low-concentration exposure similar to cosmetic products — no cycling is needed.

GHK-Cu Stacking Protocols

GHK-Cu is frequently combined with other peptides to enhance healing outcomes. Its collagen-stimulating and tissue-remodeling properties complement peptides that target different aspects of tissue repair and immune support.

GHK-Cu + BPC-157 — Comprehensive Healing Stack

The most popular GHK-Cu stack. GHK-Cu promotes collagen synthesis, tissue remodeling, and copper-dependent enzyme activity, while BPC-157 drives angiogenesis, growth factor expression, and localized tissue repair. Together they address wound healing from multiple biological angles.

CompoundDoseFrequencyPurpose
GHK-Cu1–2 mg SubQOnce dailyCollagen synthesis, tissue remodeling, anti-inflammatory
BPC-157250–500 mcg SubQOnce or twice dailyAngiogenesis, growth factor upregulation, localized repair
Protocol note: Both peptides can be injected at the same time in separate syringes. For wound healing, inject BPC-157 near the injury site and GHK-Cu in the abdomen (or also near the injury). Run both for 4–8 weeks.

GHK-Cu + Thymosin Alpha-1 — Immune + Repair Stack

This stack combines GHK-Cu's tissue repair and anti-inflammatory properties with Thymosin Alpha-1's immune-modulating effects. Thymosin Alpha-1 enhances T-cell function and immune surveillance, while GHK-Cu supports collagen remodeling and reduces inflammatory cytokines. This combination is used for post-illness recovery, chronic inflammation, and immune system support alongside tissue repair.

CompoundDoseFrequencyPurpose
GHK-Cu1 mg SubQOnce dailyTissue remodeling, collagen synthesis, anti-inflammatory
Thymosin Alpha-11.6 mg SubQ2–3x per weekImmune modulation, T-cell activation, immune surveillance

Explore more combinations with our Peptide Stack Builder or browse the Top 10 Peptide Stacks guide.

Safety, Side Effects & Contraindications

Safety Profile: GHK-Cu has demonstrated a favorable safety profile across decades of research. Topical formulations are widely used in over-the-counter cosmetics with minimal adverse effects. Injectable protocols are supported by animal studies and community experience, though formal human clinical trial data for injectable use is limited.

Injectable Side Effects

Mild and generally transient (reported by a minority of users):

  • Injection site irritation, mild redness, or minor swelling
  • Headache — occasionally reported, typically mild
  • Nausea — rare, usually transient

Topical Side Effects

Minimal:

  • Occasional mild skin irritation or redness — more common with higher concentrations or sensitive skin
  • Contact sensitivity — rare; perform a patch test before first use

Contraindications

  • Active cancer or history of cancer — GHK-Cu promotes angiogenesis and tissue remodeling. While no studies have demonstrated tumor-promoting effects, the theoretical concern exists that enhanced angiogenesis could support tumor growth. Avoid use with active malignancies.
  • Wilson's disease or copper metabolism disorders — GHK-Cu delivers copper ions. Individuals with disorders of copper metabolism (Wilson's disease, copper toxicosis) should not use GHK-Cu in any form.
  • Pregnancy and breastfeeding — no safety data exists for GHK-Cu during pregnancy or nursing. Avoid use entirely.
  • Allergy to copper compounds — individuals with known copper sensitivity or allergy should avoid GHK-Cu.

Regulatory Status

  • Injectable GHK-Cu: Not FDA-approved for human use. Classified as a research peptide.
  • Topical GHK-Cu: Widely used in over-the-counter cosmetic products. Not a drug; regulated as a cosmetic ingredient.
  • WADA status: GHK-Cu is not currently prohibited by the World Anti-Doping Agency. However, athletes should verify current status before use.
Key point: GHK-Cu is one of the few research peptides with a widely available topical form that is sold legally as a cosmetic product. The injectable form, however, remains a research peptide and is not FDA-approved. Regulations vary by jurisdiction — verify your local laws before purchasing injectable GHK-Cu.

Common GHK-Cu Dosing Mistakes

Avoid these common errors to get the most out of your GHK-Cu protocol:

Frequently Asked Questions

Key Takeaways

  • Dual-route peptide — injectable (1–2 mg/day SubQ) for systemic healing and topical (1–2% serum) for skin rejuvenation
  • Naturally occurring in human plasma — declines with age from 200 ng/mL in youth to 80 ng/mL by age 60
  • Stimulates collagen types I and III, plus decorin, elastin, and glycosaminoglycans for comprehensive skin and tissue remodeling
  • Blue/green tint in reconstituted solution is normal — caused by the copper(II) ion bound to the peptide
  • Injectable cycle: 4–8 weeks on, 4 weeks off; extended to 8–12 weeks for hair growth
  • Topical: can be used daily, ongoing — no cycling needed for cosmetic skincare use
  • Top stack: GHK-Cu + BPC-157 for comprehensive wound healing and tissue repair from complementary mechanisms
  • Contraindicated with copper metabolism disorders (Wilson's disease), active cancer, and during pregnancy/breastfeeding
  • Store reconstituted vials refrigerated at 2–8°C and use within 3–4 weeks
  • Injectable not FDA-approved — classified as a research peptide. Topical is widely available as an OTC cosmetic ingredient. Not currently prohibited by WADA.

This article is for educational and informational purposes only. See our Disclaimer.

References

  1. Pickart L. “The human tri-peptide GHK and tissue remodeling.” J Biomater Sci Polym Ed. 2008;19(8):969-988. PubMed
  2. Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.” Int J Mol Sci. 2018;19(7):1987. PubMed
  3. Maquart FX, et al. “Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.” FEBS Lett. 1988;238(2):343-346. PubMed
  4. Leyden J, et al. “Facial skin rejuvenation by copper peptide containing cream.” J Cosmet Dermatol. 2002;1(Suppl 1):S17.
  5. Pollard JD, et al. “Synthetic GHK-Cu promotes healing of segmental bone defects.” J Bone Joint Surg Am. 2005;87(Suppl 2):57-63.

Download This Guide as a PDF

Take the complete GHK-Cu Dosage Guide with you. All 13 sections, dosing tables, and FAQ — formatted for easy reference.

Free. No spam. Unsubscribe anytime.